Due to high correlations among ALDH activity, TGF-β-induced MD, and therapeutic resistance, we hypothesized that combining the inhibition of ALDH and TGF-β signaling could lead to better therapeutic effects than single treatments with any of them alone. This evidence concerns the gene LDHA and Menkes disease.